From October 1, 2023 to December 31, 2023, the company has repurchased 17,500 shares, representing 1.26% for $0.08 million. With this, the company has completed the repurchase of 57,500 shares, representing 4.05% for $0.27 million under the buyback announced on June 12, 2023.
Creative Medical Technology Holdings, Inc.
Equities
CELZ
US22529Y4089
Biotechnology & Medical Research
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
4.367 USD | -1.43% | -4.03% | -5.28% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-5.28% | 6.01M | |
+2.32% | 108B | |
+9.60% | 105B | |
+1.57% | 23.46B | |
-11.67% | 21.72B | |
-7.05% | 18.64B | |
-38.55% | 17.45B | |
-7.29% | 17.19B | |
+6.21% | 13.99B | |
+34.89% | 12.53B |
- Stock Market
- Equities
- CELZ Stock
- News Creative Medical Technology Holdings, Inc.
- Tranche Update on Creative Medical Technology Holdings, Inc.'s Equity Buyback Plan announced on June 12, 2023.